咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Treatment of gastric outlet ob... 收藏

Treatment of gastric outlet obstruction that results fromunresectable gastric cancer:Current evidence

Treatment of gastric outlet obstruction that results from unresectable gastric cancer: Current evidence

作     者:Yasuhiro Miyazaki Shuji Takiguchi Tsuyoshi Takahashi Yukinori Kurokawa Tomoki Makino Makoto Yamasaki,Kiyokazu Nakajima Masaki Mori Yuichiro Doki 

作者机构:Department of Gastroenterological SurgeryOsaka University Graduate School of MedicineSuita-shiOsaka 565-0871Japan 

出 版 物:《World Journal of Gastrointestinal Endoscopy》 (世界胃肠内镜杂志(英文版)(电子版))

年 卷 期:2016年第8卷第3期

页      面:165-172页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Gastric outlet obstruction Gastrojejunostomy Endoscopic stenting Gastric cancer Review 

摘      要:Malignant gastric outlet obstruction(GOO) is a common condition that results from locally advanced malignancies in the upper gastrointestinal tract, such as pancreatic, gastric, and other carcinomas. Two types of procedures for malignant GOO, namely, gastrojejunostomy(GJ) with laparotomy or a laparoscopic approach and endoscopic stenting(ES), are currently available. Although numerous previous reports have clarified the benefits and drawbacks of each procedure, whether GJ or ES should be used in patients with GOO that results from gastric cancer who may have a longer life expectancy than patients with other malignancies has not been determined. In this review, which focuses on gastric cancer-induced GOO, we analyzed the two systematic reviews and a meta-analysis that compared GJ and ES and outlined the current status of GOO treatment. We also provide an updated review that includes laparoscopic GJ. Various data from 13 studies in one review and 6 studies in another review were analyzed. Although the main results of the present review indicated that both GJ and ES were efficacious treatments in patients with GOO that resulted from gastric cancer, current evidence suggests that GJ may be the preferable procedure given its good performance status and improved prognosis in gastric cancer patients.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分